Chargement en cours...
An analysis of redactions in Canada’s Common Drug Review Clinical Review Reports and how they relate to the patients’ voice
IMPORTANCE: Canada’s Common Drug Review (CDR) evaluates drug data from published and unpublished research, as well as input from patient groups, to recommend provincial coverage. Currently, the CDR process gives manufacturers the opportunity to redact information in the final publicly available repo...
Enregistré dans:
| Publié dans: | BMJ Open |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
BMJ Publishing Group
2017
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5595205/ https://ncbi.nlm.nih.gov/pubmed/28893743 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bmjopen-2016-015497 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|